与PPP3CA相关的发育性和性脑病变的新变异和基因型-表型相关性
Ting Wang1, Shijia Ouyang1, Xueyang Niu2
1Children's Medical Center of Peking University First Hospital, Beijing, China.
Frontiers in neuroscience
|June 23, 2025
概括
与PPP3CA相关的发育性和性脑病变 (DEE) 与特定的遗传变异有关. 催化领域的变异与婴儿发作综合征有关,而调节领域的变异与多种发作类型和自闭症谱系障碍相关.
科学领域:
- 遗传学 是一个遗传学.
- 神经学 神经学
- 发展生物学 发展生物学
背景情况:
- 发育性和性脑病变 (DEE) 包含一组严重的早期性疾病.
- 已经确定了PPP3CA基因突变是DEE的原因,但全基因型谱和基因型-表型相关性需要进一步阐明.
研究的目的:
- 为了研究与PPP3CA相关的DEE的基因型谱.
- 在具有PPP3CA变异的个体中完善基因型-表型相关性.
主要方法:
- 在15名患者身上进行了全外体测序或全基因组测序.
- 从这些患者和21个先前发表的病例中收集和分析了临床数据.
主要成果:
- 在15名患者中发现了13种新的PPP3CA变异,包括7种新型框架转移变异和一种新型基因逆转变异.
- 在80%的患者中,发作发生在1岁之前,发作是最常见的发作类型 (93.3%).
- 催化领域 (CD) 的变异与婴儿发作综合征 (IESS) 和自闭症谱系障碍 (ASD) 的更高患病率有关,而调节领域 (RD) 的变异与多种发作类型有关.
结论:
- 这项研究报告了PPP3CA相关DEE的第一个基因逆转.
- 基因型-表型相关性表明基于PPP3CA基因 (CD与RD) 内的变异位置的不同临床表现.
- 婴儿发作综合征 (IESS) 是最常见的诊断,并伴随性ASD与CD变体更为常见.
更多相关视频
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
8.7K
06:41In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
13.8K
相关概念视频
Single Nucleotide Polymorphisms-SNPs
16.0K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.0K
Epilepsy and Seizures: Overview
296
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
296
Seizures: Classification
612
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
612
Comparing Copy Number Variations and SNPs
18.0K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.0K
Antiepileptic Drugs: GABAergic Pathway Potentiators
681
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
681
